Department of Surgery

Medicine & Life Sciences

1. Transplants 100%
2. Liver Transplantation 69%
3. Kidney 63%
4. Allografts 57%
5. Tissue Donors 51%
6. Transplant Recipients 50%
7. Kidney Transplantation 42%
8. T-Lymphocytes 41%
9. Neoplasms 35%
10. Surgeons 33%
11. Mammaplasty 33%
12. Living Donors 32%
13. Therapeutics 32%
14. Transplantation 32%
15. Pancreas Transplantation 30%
16. Survival 26%
17. Pancreas 26%
18. Wounds and Injuries 22%
19. Mortality 21%
20. Oocytes 20%
21. Lung 20%
22. Breast 20%
23. Immunosuppression 18%
24. Veterans 18%
25. Free Tissue Flaps 18%
26. Liver 18%
27. Macrophages 17%
28. Xenopus 17%
29. Graft Survival 17%
30. Sirolimus 16%
31. Infections 16%
32. Genes 16%
33. Cyclosporine 16%
34. RNA 16%
35. Regulatory T-Lymphocytes 16%
36. Graft Rejection 16%
37. Proteins 15%
38. Skin 15%
39. Incidence 15%
40. Transplantation Tolerance 15%
41. Hepatocellular Carcinoma 15%
42. Breast Neoplasms 14%
43. Blood Vessels 14%
44. Morbidity 14%
45. Recurrence 14%
46. Tuberculosis 14%
47. HIV 14%
48. Equipment and Supplies 14%
49. Population 14%
50. Technology 14%
51. Xenopus laevis 13%
52. Antibodies 13%
53. Coronavirus 13%
54. Hand 13%
55. Tacrolimus 12%
56. Pediatrics 12%
57. Pancreatic Neoplasms 12%
58. Herniorrhaphy 12%
59. Organ Transplantation 12%
60. African Americans 12%
61. thymoglobulin 12%
62. Heart 12%
63. Immunosuppressive Agents 12%
64. Peritoneal Neoplasms 11%
65. Databases 11%
66. Education 11%
67. Costs and Cost Analysis 11%
68. Zika Virus 11%
69. Safety 11%
70. Pharmaceutical Preparations 11%
71. Lymphocytes 11%
72. Pandemics 11%
73. Delivery of Health Care 11%
74. Bariatric Surgery 11%
75. In Vitro Techniques 11%
76. Perforator Flap 11%
77. Neoplasm Metastasis 11%
78. Germ Cells 10%
79. Messenger RNA 10%
80. Guidelines 10%
81. Physicians 10%
82. Registries 10%
83. Health 10%
84. Odds Ratio 10%
85. Drainage 10%
86. Abdominal Wall 9%
87. Biopsy 9%
88. Serum 9%
89. Robotics 9%
90. Lung Neoplasms 9%
91. Cohort Studies 9%
92. Intensive Care Units 9%
93. Muscles 9%
94. Dendritic Cells 9%
95. Acellular Dermis 9%
96. Swine 9%
97. Adenocarcinoma 9%
98. Confidence Intervals 9%
99. Quality Improvement 9%
100. Gastric Bypass 9%